#154783

Anti-Melanoma cells [NKIM6]

Cat. #154783

Anti-Melanoma cells [NKIM6]

Cat. #: 154783

Sub-type: Primary antibody

Unit size: 100 ug

Availability: 10-12 weeks

Target: Melanoma cells

Class: Monoclonal

Reactivity: Human

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Institute: Netherlands Cancer Institute

Tool Details
Target Details
Handling
References

Tool Details

*FOR RESEARCH USE ONLY

  • Name: Anti-Melanoma cells [NKIM6]
  • Tool sub type: Primary antibody
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Strain: Balb/c
  • Reactivity: Human
  • Host: Mouse
  • Description: Melanoma, also known as malignant melanoma, is a type of cancer that develops from the pigment-containing cells known as melanocytes. In women, they most commonly occur on the legs, while in men they are most common on the back. Sometimes they develop from a mole with changes such as an increase in size, irregular edges, change in colour, itchiness, or skin breakdown.
  • Immunogen: A mouse was immunized with cultured melanoma cells derived from a human melanoma metastasis.
  • Myeloma used: Sp2/0-Ag14

Target Details

  • Target: Melanoma cells
  • Target background: Melanoma, also known as malignant melanoma, is a type of cancer that develops from the pigment-containing cells known as melanocytes. In women, they most commonly occur on the legs, while in men they are most common on the back. Sometimes they develop from a mole with changes such as an increase in size, irregular edges, change in colour, itchiness, or skin breakdown.

Handling

  • Format: Liquid
  • Concentration: 0.9-1.1 mg/ml
  • Unit size: 100 ug
  • Storage buffer: PBS with 0.02% azide
  • Storage conditions: -15° C to -25° C
  • Shipping conditions: Shipping at 4° C

References

  • de Vries et al. 1986. Int J Cancer. 38(4):465-73. PMID: 2428758.
  • Buraggi et al. 1985. Cancer Res. 45(7):3378-87. PMID: 4005860.